Case Reports in Dermatological Medicine最新文献_第7页

Interstitial Mycosis Fungoides: An Unusual Mimic of Interstitial Granuloma Annulare Not to Miss. 间质性蕈样真菌病:一种不寻常的间质性肉芽肿的模拟物。

Case Reports in Dermatological Medicine Pub Date : 2022-09-05 eCollection Date: 2022-01-01 DOI: 10.1155/2022/3506738

Neha Singh, Kiley K Fagan, Douglas J Grider

{"title":"Interstitial Mycosis Fungoides: An Unusual Mimic of Interstitial Granuloma Annulare Not to Miss.","authors":"Neha Singh, Kiley K Fagan, Douglas J Grider","doi":"10.1155/2022/3506738","DOIUrl":"https://doi.org/10.1155/2022/3506738","url":null,"abstract":"Interstitial mycosis fungoides is a rare histopathologic variant of mycosis fungoides that may resemble interstitial granuloma annulare, inflammatory morphea, and interstitial granulomatous dermatitis. Reported is a case of a 62-year-old African American female who presented with an asymptomatic, progressive rash of the left underarm and abdomen with histologic features suggestive of granuloma annulare. Biopsies revealed an interstitial pattern of cells in the dermis with prominent small aggregates of atypical lymphocytes, a few atypical lymphocytes in the lower epidermis, and a mild increase in dermal mucin. Immunohistochemistry staining revealed the atypical lymphocytes to be positive for CD3 and CD8 and negative for CD4 and CD7, an aberrant immunoprofile. Mixed in the dermis with the atypical lymphoid cells were a few CD68 positive histiocytes and S100 protein positive dermal dendritic cells. T-cell receptor beta gene rearrangement studies showed nearly the same clonal peaks for TCRB rearrangement in two biopsy specimens from separate sites, all supporting a diagnosis of interstitial mycosis fungoides. The patient is undergoing treatment with full body narrowband UVB (nbUVB) phototherapy with notable improvement in skin discoloration and resolution of several abdominal lesions. A diagnosis of interstitial mycosis fungoides is challenging to make based on clinical features alone and is often clinically misdiagnosed. Awareness of histopathologic features is critical to make an accurate diagnosis and thus patient management.","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":" ","pages":"3506738"},"PeriodicalIF":0.0,"publicationDate":"2022-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467741/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40357970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Coexistence of Pemphigus Vulgaris and Lichen Planus following COVID-19 Vaccination. COVID-19疫苗接种后寻常型天疱疮和扁平苔藓的共存。

Case Reports in Dermatological Medicine Pub Date : 2022-08-28 eCollection Date: 2022-01-01 DOI: 10.1155/2022/2324212

Zeinab Aryanian, Kamran Balighi, Arghavan Azizpour, Kambiz Kamyab Hesari, Parvaneh Hatami

引用次数: 4

Pityriasis Versicolor Resistant to Antifungal Drugs in a Patient in Lomé (Togo). 多哥洛莫雷市1例花斑糠疹抗真菌药物耐药。

Case Reports in Dermatological Medicine Pub Date : 2022-08-22 eCollection Date: 2022-01-01 DOI: 10.1155/2022/5404913

Julienne Teclessou, Koussake Kombate, Bayaki Saka, Séfako Abla Akakpo, Palokinam Pitche

{"title":"Pityriasis Versicolor Resistant to Antifungal Drugs in a Patient in Lomé (Togo).","authors":"Julienne Teclessou, Koussake Kombate, Bayaki Saka, Séfako Abla Akakpo, Palokinam Pitche","doi":"10.1155/2022/5404913","DOIUrl":"https://doi.org/10.1155/2022/5404913","url":null,"abstract":"Background: Pityriasis versicolor (PV) is a ubiquitous superficial skin mycosis that often affects young adults. It is often effectively treated with local or oral antifungal agents. Cases of PV resistance to antifungal agents have been reported rarely. We report a case of antifungal resistant PV. Observation. A 22-year-old patient was followed since the age of 17 years in a dermatology outpatient clinic for hyperpigmented scaly macular lesions of the trunk and upper limbs. The clinical diagnosis of PV was retained. The patient was treated by fluconazole 300 mg/week before being lost to follow-up. He was seen again in 2019 (about 2 years later) for the same symptomatology and treated again by fluconazole and ciclopirox olamine cream without improvement. He was again lost to follow-up and seen again six months later. A mycological sample was taken and Aspergillus niger was isolated. The patient was treated by itraconazole for 6 weeks. The evolution was marked by a clinical status quo. The patient was again put on salicylated petroleum jelly 10% associated with terbinafine cream and then lost to follow-up.Conclusion: The emergence of fungal resistance to antifungal drugs does not spare PV. It can therefore be resistant to several antifungal drugs, leaving clinicians and patients in despair.","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":" ","pages":"5404913"},"PeriodicalIF":0.0,"publicationDate":"2022-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40332472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Nasolabial Ulcerated Placard Revealing a Primary Cutaneous Aggressive Epidermotropic CD8+ T-cell Lymphoma. 鼻唇溃疡牌显示原发性皮肤侵袭性表皮性CD8+ t细胞淋巴瘤。

Case Reports in Dermatological Medicine Pub Date : 2022-08-09 eCollection Date: 2022-01-01 DOI: 10.1155/2022/5672783

J B Ntihebuwayo, F Hali, A Kerouach, H Rachadi, S Chiheb, F Marnissi

{"title":"Nasolabial Ulcerated Placard Revealing a Primary Cutaneous Aggressive Epidermotropic CD8+ T-cell Lymphoma.","authors":"J B Ntihebuwayo, F Hali, A Kerouach, H Rachadi, S Chiheb, F Marnissi","doi":"10.1155/2022/5672783","DOIUrl":"https://doi.org/10.1155/2022/5672783","url":null,"abstract":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma is a rare entity representing less than 1% of cutaneous lymphomas. It has an aggressive clinical manifestation with a poor prognosis. It is characterized by cytotoxic and epidermotropic CD8+ proliferation. It also expresses the TIA-1 marker. We report a new case for its display and aggressive character, diagnostic difficulty, and good therapeutic response to chemotherapy. This is a 62-year-old female patient admitted to the hospital for a nasolabial ulcerated placard evolving for two years. Clinical examination revealed submandibular lymph nodes. The specimen analysis associated with anatomoclinical manifestation was concluded for a primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma. Tumor extent assessment did not show any secondary localization. The blood tests and serology were unremarkable. The patient had benefited from a CHOEP-type multidrug therapy protocol with complete healing of the lesion after three courses of chemotherapy.","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":" ","pages":"5672783"},"PeriodicalIF":0.0,"publicationDate":"2022-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381253/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40624255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Leukocytoclastic Vasculitis following the First Dose of the Elasomeran COVID-19 Vaccination. 第一剂新冠肺炎疫苗接种后的白细胞破裂性血管炎。

Case Reports in Dermatological Medicine Pub Date : 2022-08-04 eCollection Date: 2022-01-01 DOI: 10.1155/2022/1469410

Jarett J Casale, Mikél E Muse, Tara J Snow, Karen P Gould, Natalie D Depcik-Smith

{"title":"Leukocytoclastic Vasculitis following the First Dose of the Elasomeran COVID-19 Vaccination.","authors":"Jarett J Casale, Mikél E Muse, Tara J Snow, Karen P Gould, Natalie D Depcik-Smith","doi":"10.1155/2022/1469410","DOIUrl":"https://doi.org/10.1155/2022/1469410","url":null,"abstract":"Our case highlights leukocytoclastic vasculitis as a potential side effect of the elasomeran COVID-19 vaccine. As the elasomeran vaccine becomes more widely available to the public, cutaneous reactions should be noted and looked for as potential side effects of the vaccine. Our patient had a history of immune thrombocytopenic purpura, making this a potential predisposing condition to the development of vasculitis following elasomeran administration. The case of vasculitis in our patient, although diffuse in distribution, was self-resolving. Our patient was counseled of the potential risk of worsening reaction to the second dose of the vaccine and instructed to proceed at their own risk. He elected to receive the second vaccination dose without any further reaction or side effects. Primary teaching points from this case include the potential of developing leukocytoclastic vasculitis following the elasomeran vaccination. Patients who develop LCV following the first dose should be counseled of the risks associated with receiving the second dose, including progression to systemic organ involvement.","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":" ","pages":"1469410"},"PeriodicalIF":0.0,"publicationDate":"2022-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371881/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40613211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Clinical and Histopathological Findings in a Patient of Darier-White Disease with Acrokertasosis Verruciformis of Hopf. Darier-White病合并疣状肢角变性1例临床和组织病理学分析。

Case Reports in Dermatological Medicine Pub Date : 2022-07-04 eCollection Date: 2022-01-01 DOI: 10.1155/2022/5233837

Vikash Paudel, Manish Bhakta Pradhan, Brijesh Shrestha, Sumit Paudel

引用次数: 0

Isolated Langerhans Cell Histiocytosis of the Vulva in a 28-Year-Old Lady: A Report of a Case and Brief Review of the Literature. 28岁女性外阴分离朗格汉斯细胞组织细胞增多症1例报告及文献复习。

Case Reports in Dermatological Medicine Pub Date : 2022-06-28 eCollection Date: 2022-01-01 DOI: 10.1155/2022/8483008

Maryam Sadat Sadati, Nafiseh Todarbary, Fatemeh Sari Aslani, Maryam Hadibarhaghtalab

引用次数: 0

Polypoid Basal Cell Carcinoma on the Nose Tip. 鼻尖息肉样基底细胞癌。

Case Reports in Dermatological Medicine Pub Date : 2022-06-24 eCollection Date: 2022-01-01 DOI: 10.1155/2022/4087202

Mutsuki Hirakawa, Yuki Ishikura, Taketoshi Futatsuya, Reimon Yamaguchi, Akira Shimizu

引用次数: 0

Site Injection Reaction, Maculopapular Rash, and Rosacea Exacerbation after COVID-19 Vaccination 新冠肺炎疫苗接种后局部注射反应、黄斑部皮疹和红斑痤疮加重

Case Reports in Dermatological Medicine Pub Date : 2022-04-14 DOI: 10.1155/2022/9944727

Youness Benyamna, F. Marraha, I. Al Faker, H. Chahoub, Najlae Rahmani, Yasmine Rkiek, Soukayna Kabbou, D. Soussi Tanani, S. Gallouj

引用次数: 0

L-Mesitran Foam: Evaluation of a New Wound Care Product l -美西坦泡沫:一种新型伤口护理产品的评价

Case Reports in Dermatological Medicine Pub Date : 2022-04-14 DOI: 10.1155/2022/4833409

Segametsi Mary-Jane Mthanti, Gloria Pelle, N. Cremers

{"title":"L-Mesitran Foam: Evaluation of a New Wound Care Product","authors":"Segametsi Mary-Jane Mthanti, Gloria Pelle, N. Cremers","doi":"10.1155/2022/4833409","DOIUrl":"https://doi.org/10.1155/2022/4833409","url":null,"abstract":"Chronic wounds are a health problem that has devastating consequences for patients and their quality of life. Often, chronic wounds are stuck in the inflammatory phase or burdened with an infection. Therefore, it is important to find alternative all-round wound care products that have both wound healing and antimicrobial activities. New wound care products are developed constantly, implementing the latest knowledge and advances in wound care. Honey-based wound care formulations and foam dressings are increasingly used in the clinic. L-Mesitran Foam is a novel product in which a foam dressing is precoated with medical-grade honey. Here, we describe our first experiences with L-Mesitran Foam in the clinic. In this case report, a 57-year-old woman with diabetes mellitus type 2 and hypertension presented with a chronic diabetic venous leg ulcer on her leg. Treatments over six months with different treatments, including povidone-iodine, silver dressings, and compression therapy, were ineffective and subsequently switched to L-Mesitran Foam. The dressing choice was based on the wound type and complied with the instructions for use. Wound healing progressed nicely on different aspects and led to complete healing on day 23. No side effects or pain was experienced during treatment. The presented case supports the safety and efficacy of L-Mesitran Foam and serves as a proof of concept.","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":"2022 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42026826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1